The findings of a new study suggest that individuals receiving personalized combination therapy for treatment-resistant cancer may experience improved disease control and survival rates.
Can personalized high-precision drugs provide more benefits to people with metastatic cancer?
Recently, precision medicine has gained ground as a potentially more effective approach to treating a number of stubborn conditions and diseases, including many types of cancer.
With such an approach, researchers are better able to predict which types of treatments are best suited to the individual, depending on their genetic structures and their environmental and lifestyle factors.
A new study – its findings appeared in the journal Nature Medicine – Now, personalization of sensitive medicine suggests that it may be useful in the treatment of cancers that have not responded to previously prescribed treatments.
Researchers in San Diego, many of whom are from La Jolla, California, are a clinical study to test whether a personalized combination therapy has a positive effect on people with refractory tumors. These are tumors that do not respond to previous treatment.
To find the best combination therapy match, they analyzed participants' specific tumor mutations and attempted to target them individually.
First author. Jason K. Sicklick, "Response to treatments that target a change may be low and not durable," he says. Ti Our approach went beyond targeting a single change. Together with a very dedicated team of oncologists, we have created a personalized combination therapy for each patient. K
The post Cancer: High personalized therapy appeared to improve the results of the first on Binbon.
Get real time update about this post categories directly on your device, subscribe now.